Newsroom
BioLamina further Strengthens Leadership by appointing Pia van der Zee as Chief Commercial Officer
Pia van der Zee brings in years of experience in the global life science industry with commercial know-how in business development, sales, and marketing.
March 7, 2022
-
BioLamina further Strengthens Leadership by appointing Pia van der Zee as Chief Commercial Officer
-
BioLamina with partners in the innovation milieu IndiCell receive SEK 40M to establish and propel individualized cell therapy treatments in Sweden
-
Appointment of new CEO at BioLamina AB
-
BioLamina AB expands production and office space to meet the fast-growing customer demand
-
BioLamina AB and Inventia Life Science partner to advance cell matrices for complex 3D cell models
-
BioLamina AB launches new website
-
BioLamina AB and partners granted € 6.1M in funding to develop organ-on-chip system for animal-free modelling of human diseases
-
BioLamina and Cellaria will collaborate to make accurate cell models for drug screening
-
Biolamina and Spiber Technologies sign exclusive sales and marketing deal for unique Biosilk products
-
Stay updated on the latest publications and offers by signing up to the BioLamina Newsletter
-
BioLamina and Novo Nordisk partner to advance stem cell based therapies for three common medical conditions
-
BioLamina and partners aim to develop new methods to differentiate unlimited amounts of NK-cells to fight cancer
-
BioLamina announces an OEM partnership with Cellink for the development of biologically relevant bioink products for bioprinting
-
Webcast series: Rising stars
-
Customer testimonials
-
Founder of BioLamina: Karl Tryggvason